When initiating SGLT-2 therapy in a patient with heart failu…
When initiating SGLT-2 therapy in a patient with heart failure, it is important to monitor: thyroid function and serum calcium levels. volume status and renal function. serum calcium and potassium levels. platelet count and thyroid function.
Read DetailsP2Y12 receptor inhibitors decrease platelet aggregation thro…
P2Y12 receptor inhibitors decrease platelet aggregation through which pharmacodynamic action? Prevention of ADP-mediated activation of GP IIb/IIIa receptors Enhancement of prostacyclin production Direct degradation of fibrin strands Inhibition of thromboxane A2 synthesis
Read DetailsWhen prescribing oral iron, which dosing strategy may improv…
When prescribing oral iron, which dosing strategy may improve adherence and absorption? High daily doses to saturate transport proteins Lower or alternate-day dosing Dividing doses every two hours Taking iron only when symptomatic
Read DetailsAspirin reduces platelet aggregation primarily through which…
Aspirin reduces platelet aggregation primarily through which mechanism? Irreversible inhibition of cyclooxygenase-1 leading to decreased thromboxane A? production Reversible blockade of adenosine diphosphate receptors on platelets Direct inhibition of thrombin formation Activation of antithrombin leading to factor Xa inhibition
Read Details